This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.



  • Thesis defense Willeke Ros

    While some immunotherapies already help cancer patients, many more of this type of drugs that are aimed at encouraging the immune system to fight cancer are being developed. During her PhD research Willeke Ros studied the efficacy and safety of several of those medicines in the first patients. She also investigated whether the already registered immunotherapy pembrolizumab could be effective against rare tumors.

    Read More
  • Research into the quality of life in cancer patients in the palliative care phase: Lonneke van de Poll on the eQuiPe study

    Strange as this may sound, very little is known about the quality of life of terminal cancer patients in the palliative care phase. Medical practitioners are often uncertain of what they can still offer such patients, their relatives and carers. The eQuiPe study is going to change this state of affairs. 

    Read More
  • More news

Comprehensive Cancer Centre

'The Netherlands Cancer Institute, a center of excellence for the benefit of cancer patients.'

Support Us